Amrize Ltd (AMRZ) Stock Analysis
Is AMRZ a good investment?
Amrize Ltd (AMRZ) has a Plutrex AI rating of 78.0/100 as of July 10, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 0.84 represents a 49.4% discount to the industry average of 1.662 — AMRZ is the most attractively valued stock in the Construction Materials peer group on a growth-adjusted basis, with analyst consensus target of $63.60 implying 17.8% upside from $54.01. Main concern: Operating margin of -3.5% vs. industry average 10.2% — a 13.74 percentage point gap that is UNCHANGED from prior report; core operations remain unprofitable while all 17 industry peers generate meaningful operating profit; net margin of 9.7% is entirely dependent on non-operating income that could normalize, collapsing reported profitability.
Investment Summary
Amrize (AMRZ) at $54.01 presents a compelling growth-at-a-discount story in the Construction Materials sector, anchored by a PEG ratio of 0.84 (vs. industry average 1.662 — a 49.4% discount) and a 5-year EPS growth projection of 20.1% (vs. industry average 13.4%). The analyst consensus target of $63.60 implies 17.8% upside. The $1 billion share buyback program — the largest investment in the Canadian cement industry in a decade — is the critical catalyst that bridges the credibility gap between tepid revenue growth (4.7% YoY vs. industry 6.43%) and the ambitious EPS growth projection. The core structural concern remains: operating margin of -3.5% vs. industry average of 10.2% — a 13.74 percentage point gap that means core operations are loss-making while peers are profitable. Net margin of 9.7% is sustained by non-operating income, not operational excellence. However, the $1B buyback mechanically boosts EPS even without margin improvement, the Montreal cement plant modernization signals long-term operational investment, and reaffirmed 2026 guidance reduces near-term uncertainty. Free cash flow of $1.371 billion (exceeding net income) and debt-to-equity of 0.44 (vs. industry 0.724) confirm the buyback is financially credible. Stock is down 2.4% from prior report ($55.35 → $54.01), creating a marginally better entry point with fundamentals essentially unchanged.
Key Strengths
- PEG ratio of 0.84 represents a 49.4% discount to the industry average of 1.662 — AMRZ is the most attractively valued stock in the Construction Materials peer group on a growth-adjusted basis, with analyst consensus target of $63.60 implying 17.8% upside from $54.01
- $1 billion share buyback program (commencing May 6, 2026) is credible given FCF of $1.371B and cash of $1.099B — mechanically boosts EPS even without margin improvement, directly addressing the revenue growth vs. EPS growth credibility gap; combined with Montreal cement plant modernization (largest Canadian cement investment in a decade), strategic momentum is building
- Debt-to-equity of 0.44 vs. industry average 0.724 (39.2% less leveraged) with FCF of $1.371B provides exceptional financial flexibility in a cyclical sector — balance sheet strength supports both the buyback and long-term capital investment without financial stress
Key Concerns
- Operating margin of -3.5% vs. industry average 10.2% — a 13.74 percentage point gap that is UNCHANGED from prior report; core operations remain unprofitable while all 17 industry peers generate meaningful operating profit; net margin of 9.7% is entirely dependent on non-operating income that could normalize, collapsing reported profitability
- Revenue growth of 4.7% YoY (UNCHANGED from prior report) vs. industry 6.43% creates an unresolved credibility gap with 20.1% projected 5-year EPS growth — historical EPS growth remains N/A, meaning there is zero verified track record to validate forward projections; the buyback helps mechanically but does not solve the underlying operational leverage question
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
AMRZ's fundamentals present a classic 'operational turnaround with strong cash generation' profile. Profitability: Gross margin 25.3% (vs. industry 30.6% — 17.5% below peers), operating margin -3.5% (vs. industry 10.2% — catastrophic 13.7pp gap), net margin 9.7% (vs. industry 11.8% — 17.5% below peers, but sustained by non-operating income). ROE 10.1% (vs. industry 13.2% — 23.6% below peers). These metrics confirm AMRZ's core business is not yet generating operating profit, which is the single most important fundamental concern. Valuation: P/E 25.84x (vs. industry 32.25x — 19.9% discount), PEG 0.84 (vs. industry 1.662 — 49.4% discount), P/B 2.28x (reasonable for 10.1% ROE). The PEG discount is the primary valuation signal — market is not pricing in the 20.1% 5-year EPS growth rate. Growth: Revenue growth 4.7% YoY (vs. industry 6.43% — 26.9% below peers), next-year EPS growth 14.7%, 5-year EPS growth 20.1% (vs. industry 13.4% — 49.7% premium). Historical EPS growth N/A — no track record to validate projections. Financial Health: Cash $1.099B, FCF $1.371B (exceeds net income — strong real cash generation), debt-to-equity 0.44 (vs. industry 0.724 — 39.2% less leveraged). The FCF strength is what makes the $1B buyback credible and the balance sheet conservative despite operational losses.
News Sentiment
Amrize is making bold moves that could reshape its future — and investors are taking notice. The Canadian construction materials giant recently launched a $1 billion share buyback program, a massive vote of confidence from management that signals they believe the stock is undervalued at current prices. The buyback, which kicks off May 6, 2026, is being called the largest investment in the Canadian cement industry in over a decade — a headline that underscores just how significant this moment is for the company. On the operational front, Amrize is modernizing its Montreal-area cement plant to become the most advanced facility in Eastern Canada, a strategic move that positions the company for long-term efficiency gains and competitive advantages in a sector where infrastructure spending is accelerating. The company also reported first-quarter revenue growth of 4.7% and — crucially — reaffirmed its full-year 2026 guidance, giving investors confidence that management sees no major headwinds on the horizon. That guidance reaffirmation is particularly important because it removes near-term uncertainty and validates the company's earnings projections. With approximately 19,000 employees and multi-year supply agreements for major infrastructure projects providing revenue stability, Amrize is positioning itself as a long-term infrastructure play. The combination of the buyback, plant modernization, and steady guidance paints a picture of a company investing in its future while returning capital to shareholders — a rare combination that typically signals management confidence in the business trajectory.
Risk Assessment
PRIMARY RISK: Operating margin normalization failure — if non-operating income that sustains the 9.7% net margin declines or reverses, reported profitability collapses and the EPS growth thesis breaks. Mitigation: Monitor quarterly non-operating income line items and watch for operating margin trend improvement as Montreal plant modernization progresses. SECONDARY RISK: EPS growth projection credibility — 20.1% 5-year EPS growth with only 4.7% revenue growth requires significant margin expansion and/or buyback contribution; if margin expansion stalls, forward estimates will be revised down. Mitigation: $1B buyback provides mechanical EPS support even in flat-margin scenario. TERTIARY RISK: Construction sector cyclicality — AMRZ operates in a capital-intensive, economically sensitive sector; a construction downturn would pressure both revenue and the non-operating income that sustains net margins. Mitigation: Conservative debt-to-equity of 0.44 and $1.099B cash provide recession buffer. STOP-LOSS at $49.50 represents ~8.3% downside from entry price of $54.00, set below key support and prior report's lower bound, providing cushion for Q2 margin disappointment without triggering on normal volatility.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is AMRZ a halal stock?
No, Amrize Ltd (AMRZ) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for AMRZ?
Amrize Ltd (AMRZ) has a Plutrex AI rating of 78.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is AMRZ a good investment?
According to Plutrex AI, AMRZ has a Buy rating (78.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in AMRZ?
US stocks like AMRZ can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in AMRZ?
Plutrex AI identifies the main risks for AMRZ by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.